Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chigusa Kitayama

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Scientific Reports|September 4, 2021
The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trialKiyotaka Uchiyama, Chigusa Kitayama, Akane Yanai, et al.
CEN Case Reports|November 24, 2021
Renal recovery following daratumumab, lenalidomide, and dexamethasone therapy in a patient with newly diagnosed dialysis-dependent multiple myelomaShinichi Mizuno, Chigusa Kitayama, Shigeto Mashiko, et al.
CEN Case Reports|April 28, 2021
Bortezomib-induced glomerular microangiopathy complicated with monoclonal immunoglobulin deposition diseaseShinichi Mizuno, Chigusa Kitayama, Satoru Sanada, et al.
International Journal of Hematology|July 26, 2020
Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethasone regimenShinichi Mizuno, Chigusa Kitayama, Kenta Yamaguchi, et al.
American Journal of Physiology. Renal Physiology|September 2, 2025
The organelle tethering protein PDZD8 regulates endolysosomal maturation and TLR9-NF-κB signaling in cisplatin-induced acute kidney injuryYuto Takenaka, Hiroshi Maekawa, Yu Ah Hong, et al.
JCI Insight|August 8, 2024
Organelle communication maintains mitochondrial and endosomal homeostasis during podocyte lipotoxicitySho Hasegawa, Masaomi Nangaku, Yuto Takenaka, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Scientific Reports|September 4, 2021
The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trialKiyotaka Uchiyama, Chigusa Kitayama, Akane Yanai, et al.
CEN Case Reports|November 24, 2021
Renal recovery following daratumumab, lenalidomide, and dexamethasone therapy in a patient with newly diagnosed dialysis-dependent multiple myelomaShinichi Mizuno, Chigusa Kitayama, Shigeto Mashiko, et al.
CEN Case Reports|April 28, 2021
Bortezomib-induced glomerular microangiopathy complicated with monoclonal immunoglobulin deposition diseaseShinichi Mizuno, Chigusa Kitayama, Satoru Sanada, et al.
International Journal of Hematology|July 26, 2020
Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethasone regimenShinichi Mizuno, Chigusa Kitayama, Kenta Yamaguchi, et al.
American Journal of Physiology. Renal Physiology|September 2, 2025
The organelle tethering protein PDZD8 regulates endolysosomal maturation and TLR9-NF-κB signaling in cisplatin-induced acute kidney injuryYuto Takenaka, Hiroshi Maekawa, Yu Ah Hong, et al.
JCI Insight|August 8, 2024
Organelle communication maintains mitochondrial and endosomal homeostasis during podocyte lipotoxicitySho Hasegawa, Masaomi Nangaku, Yuto Takenaka, et al.
Pageof 1